¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦5ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¿¬¼ö°­ÁÂ(Updates of Guidelines in Criticall Illness) : 2021-11-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦5ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¿¬¼ö°­ÁÂ(Updates of Guidelines in Criticall Illness) : 2021-11-20
±³À°ÀÏÀÚ : 2021-11-20
±³À°Àå¼Ò : ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦5ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¿¬¼ö°­ÁÂ(Updates of Guidelines in Criticall Illness)
ÁÖÃÖ±â°ü : ´ëÇÑÁßȯÀÚÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ  
´ã´çÀÚ : ±è¾Ö¸®
¿¬¶ôó : 02-744-7888  
À̸ÞÀÏ : kspccm@kspccm      
±³À°Á¾·ù : ±âŸ      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ : 5¸¸¿ø Àü°øÀÇ : 2¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ09:10~09:40 Experience of Critically Ill Children with COVID-19 in USA  Thomas V. Brogan(PICU Seattle Children) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ09:40~10:10 Experience of Critically Ill Children with COVID-19 in Italy  Matteo Di Nardo(PICU Children) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ10:10~10:40 Pediatric COVID-19 Experience in Korea  ÃÖ¿µÁØ(°í·ÁÀÇ´ë) 
È޽Ġ11-20  10:40~10:50 È޽Ġ () 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ10:50~11:20 Diagnosis and Management of MIS-C  °ûÁöÈñ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ11:20~11:50 PICU Guidelines in Management of Pediatric COVID-19  ÃÖÀ¯Çö(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ11:50~12:20 Vaccination Guidelines for COVID-19 in Critically Ill Patients  ±ÇÁ¤Àº(°æºÏÀÇ´ë) 
½Ä»ç 11-20  12:20~13:20 ½Ä»ç  () 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ13:20~13:40 Neurologic Monitoring and Neurocritical Care in Post Cardiac Arrest  ±è¿µ¾Æ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ13:40~14:00 Long Term Neurologic Performance in Post CPR Patients  ±è¼ö¿¬(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ14:00~14:20 Diagnosis and Management of Myocarditis  Á¶Áß¹ü(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ14:20~14:40 ECMO for Myocarditis in Children  ±ÇÇý¿ø(¼­¿ïÀÇ´ë) 
È޽Ġ11-20  14:40~14:50 È޽Ġ () 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ14:50~15:10 Recognising Sepsis in Children  ÃÖÀμö(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-20 ¿Â¶óÀΠ15:10~15:30 Management of Sepsis in Children  Ã־ƿµ(Ãæ³²ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦5ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¿¬¼ö°­ÁÂ(Updates of Guidelines in Criticall Illness) : 2021-11-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹¿©¼ºÁ¤½ÅÀÇÇÐȸ (¿Â¶óÀÎ) ÄÚºñµå-19 ´ëÀ¯Çà½Ã±âÀÇ Çзɱ⠾Ƶ¿ÀÇ Çо÷ : 2021-11-20
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ 2021³â Ã߰迬¼ö°­Á : 2021-11-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 19 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 26 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 14 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 18 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 21 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 20 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 20 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 11 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 12 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 7 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 16 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 15 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 10 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 13 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷